132 related articles for article (PubMed ID: 35514022)
21. High prevalence of hypogonadism determined by serum free testosterone level in Japanese testicular cancer survivors.
Kurobe M; Kawai K; Suetomi T; Iwamoto T; Waku N; Kawahara T; Kojima T; Joraku A; Miyazaki J; Nishiyama H
Int J Urol; 2018 May; 25(5):457-462. PubMed ID: 29478250
[TBL] [Abstract][Full Text] [Related]
22. Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.
Steggink LC; van Beek AP; Boer H; Meijer C; Lubberts S; Oosting SF; de Jong IJ; van Ginkel RJ; Lefrandt JD; Gietema JA; Nuver J
Andrology; 2019 Jul; 7(4):441-448. PubMed ID: 30609309
[TBL] [Abstract][Full Text] [Related]
23. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
24. Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial.
Walsh JS; Marshall H; Smith IL; Greenfield DM; Swain J; Best E; Ashton J; Brown JM; Huddart R; Coleman RE; Snowden JA; Ross RJ
PLoS Med; 2019 Nov; 16(11):e1002960. PubMed ID: 31714912
[TBL] [Abstract][Full Text] [Related]
25. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer.
Petersen PM; Skakkebaek NE; Vistisen K; Rørth M; Giwercman A
J Clin Oncol; 1999 Mar; 17(3):941-7. PubMed ID: 10071288
[TBL] [Abstract][Full Text] [Related]
26. Quantification of the Leydig cell compartment in testicular biopsies and association with biochemical Leydig cell dysfunction in testicular cancer survivors.
Tarsitano MG; Bandak M; Jørgensen N; Skakkebaek NE; Juul A; Lenzi A; Daugaard G; Rajpert-De Meyts E
Andrology; 2018 Sep; 6(5):748-755. PubMed ID: 29981219
[TBL] [Abstract][Full Text] [Related]
27. Testosterone replacement therapy for hypogonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial.
Seidman SN; Spatz E; Rizzo C; Roose SP
J Clin Psychiatry; 2001 Jun; 62(6):406-12. PubMed ID: 11465516
[TBL] [Abstract][Full Text] [Related]
28. The effects of hypogonadism on quality of life in survivors of germ cell tumors treated with surgery alone versus surgery plus platinum-based chemotherapy.
Khanal N; Ahmed SS; Kalra M; Miller TJ; Brames MJ; Stump TE; Monahan P; Hanna NH; Einhorn LH
Support Care Cancer; 2020 Jul; 28(7):3165-3170. PubMed ID: 31707501
[TBL] [Abstract][Full Text] [Related]
29. Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus.
Shigehara K; Konaka H; Kato Y; Iijima M; Nakashima K; Kawaguchi S; Nohara T; Izumi K; Namiki M; Mizokami A
Int J Impot Res; 2019 Jan; 31(1):25-30. PubMed ID: 30135606
[TBL] [Abstract][Full Text] [Related]
30. Chronic fatigue in 812 testicular cancer survivors during long-term follow-up: increasing prevalence and risk factors.
Sprauten M; Haugnes HS; Brydøy M; Kiserud C; Tandstad T; Bjøro T; Bjerner J; Cvancarova M; Fosså SD; Oldenburg J
Ann Oncol; 2015 Oct; 26(10):2133-40. PubMed ID: 26265167
[TBL] [Abstract][Full Text] [Related]
31. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
32. Systematic Review of the Impact of Testosterone Replacement Therapy on Depression in Patients with Late-onset Testosterone Deficiency.
Vartolomei MD; Kimura S; Vartolomei L; Shariat SF
Eur Urol Focus; 2020 Jan; 6(1):170-177. PubMed ID: 30017901
[TBL] [Abstract][Full Text] [Related]
33. Gonadal function of patients treated with cisplatin based chemotherapy for germ cell cancer.
Brennemann W; Stoffel-Wagner B; Helmers A; Mezger J; Jäger N; Klingmüller D
J Urol; 1997 Sep; 158(3 Pt 1):844-50. PubMed ID: 9258096
[TBL] [Abstract][Full Text] [Related]
34. Preorchiectomy Leydig Cell Dysfunction in Patients With Testicular Cancer.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Gundgaard Kier MG; Mortensen MS; Daugaard G
Clin Genitourin Cancer; 2017 Feb; 15(1):e37-e43. PubMed ID: 27524512
[TBL] [Abstract][Full Text] [Related]
35. Longitudinal assessment of Leydig cell function in male survivors of childhood cancer.
Thrope A; Gerber LM; Thomas C; Antal Z
Pediatr Blood Cancer; 2024 Mar; 71(3):e30829. PubMed ID: 38149843
[TBL] [Abstract][Full Text] [Related]
36. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms.
Leibowitz RL; Dorff TB; Tucker S; Symanowski J; Vogelzang NJ
BJU Int; 2010 May; 105(10):1397-401. PubMed ID: 19912179
[TBL] [Abstract][Full Text] [Related]
37. Altered Leydig cell function in patients with testicular cancer: evidence for bilateral testicular defect.
Willemse PH; Sleijfer DT; Sluiter WJ; Schraffordt Koops H; Doorenbos H
Acta Endocrinol (Copenh); 1983 Apr; 102(4):616-24. PubMed ID: 6133401
[TBL] [Abstract][Full Text] [Related]
38. Leydig Cell Function in Male Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study.
Chemaitilly W; Liu Q; van Iersel L; Ness KK; Li Z; Wilson CL; Brinkman TM; Klosky JL; Barnes N; Clark KL; Howell RM; Smith SA; Krasin MJ; Metzger ML; Armstrong GT; Bishop MW; van Santen HM; Pui CH; Srivastava DK; Yasui Y; Hudson MM; Robison LL; Green DM; Sklar CA
J Clin Oncol; 2019 Nov; 37(32):3018-3031. PubMed ID: 31557085
[TBL] [Abstract][Full Text] [Related]
39. Altered bone status in unilateral testicular cancer survivors: Role of CYP2R1 and its luteinizing hormone-dependency.
Foresta C; Selice R; De Toni L; Di Mambro A; Carraro U; Plebani M; Garolla A
J Endocrinol Invest; 2013 Jun; 36(6):379-84. PubMed ID: 23047203
[TBL] [Abstract][Full Text] [Related]
40. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]